These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2148636)

  • 1. Experimental studies of immunologically mediated enteropathy. VI. Inhibition of acute intestinal graft-versus-host reaction in mice by 2'-deoxyguanosine.
    Felstein MV; Mowat AM
    Scand J Immunol; 1990 Nov; 32(5):461-9. PubMed ID: 2148636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental studies of immunologically mediated enteropathy: IV. Correlation between immune effector mechanisms and type of enteropathy during a GvHR in neonatal mice of different ages.
    Felstein MV; Mowat AM
    Clin Exp Immunol; 1988 Apr; 72(1):108-12. PubMed ID: 3396213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental studies of immunologically mediated enteropathy. V. Destructive enteropathy during an acute graft-versus-host reaction in adult BDF1 mice.
    Mowat AM; Felstein MV
    Clin Exp Immunol; 1990 Feb; 79(2):279-84. PubMed ID: 2138068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction.
    Mowat AM
    Immunology; 1989 Sep; 68(1):18-23. PubMed ID: 2509325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental studies of immunologically mediated enteropathy. III. Severe and progressive enteropathy during a graft-versus-host reaction in athymic mice.
    Mowat AM; Felstein MV; Baca ME
    Immunology; 1987 Jun; 61(2):185-8. PubMed ID: 3496272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies of immunologically mediated enteropathy. Development of cell mediated immunity and intestinal pathology during a graft-versus-host reaction in irradiated mice.
    Mowat AM; Felstein MV; Borland A; Parrott DM
    Gut; 1988 Jul; 29(7):949-56. PubMed ID: 3294125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of proliferative and destructive graft-versus-host reactions in the small intestine.
    Felstein MV; Mowat AM
    Adv Exp Med Biol; 1987; 216A():653-60. PubMed ID: 3687547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental studies of immunologically mediated enteropathy. II. Role of natural killer cells in the intestinal phase of murine graft-versus-host reaction.
    Mowat AM; Felstein MV
    Immunology; 1987 Jun; 61(2):179-83. PubMed ID: 3596637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of intestinal graft-versus-host reactions across mutant major histocompatibility antigens by T lymphocyte subsets in mice.
    Mowat AM; Sprent J
    Transplantation; 1989 May; 47(5):857-63. PubMed ID: 2655224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential influence of 2'-deoxyguanosine on the induction and expression of suppressor T lymphocytes in vivo.
    Bril H; van den Akker TW; Hussaarts-Odijk LM; Benner R
    Cell Immunol; 1985 Feb; 90(2):531-8. PubMed ID: 3155658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interferon alpha/beta in the induction of intestinal pathology in mice.
    Garside P; Felstein MV; Green EA; Mowat AM
    Immunology; 1991 Oct; 74(2):279-83. PubMed ID: 1748474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
    Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
    J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for interleukin-1 alpha in immunologically mediated intestinal pathology.
    Mowat AM; Hutton AK; Garside P; Steel M
    Immunology; 1993 Sep; 80(1):110-5. PubMed ID: 8244450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for IL-4 in immunologically mediated enteropathy.
    Mowat AM; Widmer MB
    Clin Exp Immunol; 1995 Jan; 99(1):65-9. PubMed ID: 7813111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection from lethal graft-vs.-host disease by donor stem cell repopulation.
    Rozendaal L; Pals ST; Melief CJ; Gleichmann E
    Eur J Immunol; 1992 Feb; 22(2):575-9. PubMed ID: 1347016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential effect of 2-deoxyguanosine on concanavalin A-induced suppressor and cytotoxic activity.
    Varey AM; Lelchuk R; Hutchings P; Cooke A
    Cell Immunol; 1983 Oct; 81(1):99-104. PubMed ID: 6225531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of intestinal and peripheral natural killer cell activity during the graft-versus-host reaction in mice.
    Borland A; Mowat AM; Parrott DM
    Transplantation; 1983 Nov; 36(5):513-9. PubMed ID: 6605602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.